BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SECURMARK

    MDR report key: 21014470 · Received December 24, 2024

    Report

    Report Number
    1222780-2024-00502
    Event Type
    Injury
    Date Received
    December 24, 2024
    Date of Event
    February 15, 2024
    Report Date
    November 11, 2025
    Manufacturer
    HOLOGIC, INC
    Product Code
    NEU
    UDI-DI
    05420045503611
    PMA / PMN Number
    K062528
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    WI, US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    DURING THE INVESTIGATION THE CORRECT PART NUMBER WAS IDENTIFIED AS SMARK-EVIVA-13 ACCORDING TO THE MEDWATCH REPORT.

    Additional Manufacturer Narrative · 0

    LOT AND SERIAL NUMBER OF THE DEVICE NOT PROVIDED BY THE COMPLAINANT; THEREFORE, THE UDI, EXPIRATION AND MANUFACTURING DATES ARE NOT KNOWN. DEVICE HISTORY RECORD (DHR) REVIEW WAS UNABLE TO BE CONDUCTED FOR THE DISPOSABLE DEVICE AS THE IDENTIFICATION NUMBERS WERE NOT PROVIDED BY THE COMPLAINANT. THE DEVICE INVOLVED IN THIS EVENT WAS NOT RETURNED FOR EVALUATION PURPOSES THEREFORE VISUAL AND FUNCTIONAL ANALYSIS OF THE PRODUCT COULD NOT BE PERFORMED. WE ARE UNABLE TO CONFIRM A RELATIONSHIP BETWEEN THE DEVICE AND THE ISSUE REPORTED. THE INFORMATION OBTAINED DURING COMPLAINT INVESTIGATION WILL BE INCLUDED IN OUR GLOBAL COMPLAINT TRENDING AND PRODUCT SURVEILLANCE WILL CONTINUE TO MONITOR COMPLAINTS OF THIS TYPE FOR ADVERSE TRENDS. IF THE PRODUCT IS RECEIVED OR ADDITIONAL INFORMATION IS OBTAINED, THE INVESTIGATION WILL BE REOPENED ACCORDINGLY PER STANDARD OPERATING PROCEDURE.

    Additional Manufacturer Narrative · 0

    AN INVESTIGATION WAS COMPLETED: IT WAS REPORTED THAT ON (B)(6) 2024, DURING A BREVERA PROCEDURE, A TUMARK PROFESSIONAL MARKER WAS DEPLOYED. THE PATIENT REPORTED SIGNIFICANT BLEEDING AFTER THE PROCEDURE AND STATED THAT THE MARKER HAD MIGRATED APPROXIMATELY 2.5 CM. LATER, THE PATIENT CONTINUED TO EXPERIENCE BLEEDING, AND PAIN BEGAN WITHIN A FEW DAYS. THE INCISION ALSO STARTED TO ITCH INTENSELY. AN MRI SCAN WAS SCHEDULED, BUT THE CANCER COULD NOT BE LOCATED DUE TO SEVERAL FACTORS, INCLUDING DENSE BREAST TISSUE, POOR VISIBILITY, AND MIGRATION OF THE MARKER. AS A RESULT, THE PROVIDER USED TWO ADDITIONAL MARKERS¿SECURMARK FOR EVIVA, TOPHAT, AND MINICORK¿TO MARK THE BIOPSY SITES. THE PATIENT REPORTED THAT THE SECOND MARKER IMPLANTATION WAS EXTREMELY PAINFUL. PATHOLOGY RESULTS WERE RECEIVED, AND THE PROVIDER RECOMMENDED A DIGITAL MOTION X-RAY WITH IMPLANTS TO AVOID DISFIGUREMENT. DURING THIS TIME, THE MARKERS APPEARED TO CAUSE IRRITATION, AND THE PATIENT REPORTED CHEST PAIN. A SECOND MEDICAL OPINION WAS REQUESTED, WHICH LED TO A LUMPECTOMY ON AN UNKNOWN DATE. AN ELUCENT SMARTCLIP WAS PLACED THE DAY BEFORE THE PROCEDURE. DURING THE LUMPECTOMY, ONE OF THE MARKERS FELL OUT UPON INCISION DUE TO ITS SUPERFICIAL POSITION IN THE SUPERIOR ANTERIOR MARGIN. ACCORDING TO THE RECORDS, IT WAS SUTURED BACK IN PLACE. IT IS UNCLEAR WHICH MARKER THE PATIENT WAS REFERRING TO, AND FURTHER FOLLOW-UP ATTEMPTS FOR CLARIFICATION WERE NOT ANSWERED. THE DEVICE WAS NOT AVAILABLE FOR RETURN; VISUAL AND FUNCTIONAL ANALYSIS/TESTING COULD NOT BE CONDUCTED FOR THE DESCRIBED EVENT. THE SAMPLE WAS NOT RETURNED FOR THIS COMPLAINT AND THERE WAS LIMITED PATIENT-RELATED INFORMATION PROVIDED FOR THIS EVENT; THEREFORE, A THOROUGH INVESTIGATION WAS NOT CARRIED OUT. INVESTIGATION FOR THIS ISSUE WAS CONDUCTED THROUGH CUSTOMER PROVIDED INFORMATION, HISTORICAL DATA REVIEW, SIMILAR COMPLAINTS ANALYSIS, AND PRODUCT DESIGN EVALUATION. WITHOUT THE RETURNED SAMPLE, IT IS NOT POSSIBLE TO CONFIRM A DEFINITIVE ROOT CAUSE OF THE ISSUE. CONCLUSION: THE REPORTED ISSUE COULD NOT BE CONFIRMED BECAUSE THE DEVICE WAS NOT RETURNED. THE INVESTIGATION SUGGESTS THIS IS NOT A RECURRING ISSUE WITHIN THE PRODUCT FAMILY, SYSTEM, OR FAILURE MODE REFERENCED IN THE COMPLAINT. CAPA/HRA/NCR/SCAR ARE NOT DEEMED REQUIRED AT THIS MOMENT BY THIS EVENT. FUTURE EVENTS WILL BE MONITORED AND TRENDED. DEVICE HISTORY RECORD (DHR) REVIEW: THE DHR REVIEW WAS NOT CONDUCTED SINCE THE LOT/SERIAL NUMBER WAS NOT PROVIDED BY THE COMPLAINANT.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT ON (B)(6) 2024 DURING A BREVERA PROCEDURE, A TUMARK PROFESSIONAL MARKER WAS DEPLOYED. PATIENT REPORTED THAT IT BLED CONSIDERABLY AFTER THE PROCEDURE WAND THAT THE MARKER HAD MIGRATED 2.5 CM. LATER PATIENT REPORTED SHE KEPT BLEEDING AND THAT PAIN STARTED WITHIN DAYS AND THE INCISION BEGAN TO ITCH INTENSELY. PATIENT REPORTED THAT A MRI SCAN WAS SCHEDULED AND THAT THE CANCER WAS UNABLE TO BE FOUND AT THE TIME DUE TO MULTIPLE FACTORS SUCH AS DENSE BREASTS, LACK OF VISIBILITY AND THE MIGRATION OF THE MARKER. DUE TO THIS THE PROVIDER USED 2 ADDITIONAL MARKERS A SECURMARK FOR EVIVA, TOPHAT AND MINICORK TO MARK THE BIOPSY SITES. THE PATIENT REPORTED THAT THE SECOND MARKER IMPLANTATION WAS EXTREMELY PAINFULL AND THAT PATHOLOGY CAME BACK WHICH THE PROVIDED RECOMMENDED A DIGITAL MOTION X-RAY WITH IMPLANTS TO AVOID DISFIGUREMENT. DURING THAT PERIOD THE MARKERS SEEMED TO IRRITATE AND CHEST PAIN WAS REPORTED. A 2ND MEDICAL OPINION WAS REQUESTED WHICH RESULTED IN A LUMPECTOMY ON AN UNKNOWN DATE WITH A ELUCENT SMARTCLIP PLACED ON THE DAY PRIOR. DURING THE LUMPECTOMY THE MARKER FELL UPON INCISION DUE TO THE SUPERFICIAL POSITION IN THE SUPERIOR ANTERIOR MARGIN. PER THE RECORDS IT WAS SUTURED BACK IN. IT IS UNCLEAR WHICH MARKER THE PATIENT WAS REFERRING TO, ADDITIONAL FOLLOW UP FOR INFORMATION WERE NOT REPLIED

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    204568 SECURMARK MARKER, RADIOGRAPHIC, IMPLANTABLE NEU HOLOGIC, INC SMARK-EVIVA-13 05420045503611

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown Other